Patents by Inventor Stuart Mudge

Stuart Mudge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11938295
    Abstract: Ingestible devices can directly deliver therapeutic agents to desired tissue(s) of the GI tract of a subject, such as the submucosa, the mucosa, and/or the mucus layer of the GI tract, and methods of using the same. The ingestible devices can deliver therapeutic agents in a safe, effective, and reliable manner. The disclosure also provides pharmaceutical compositions for use in methods of treating a disease or condition in a subject in need thereof.
    Type: Grant
    Filed: September 15, 2022
    Date of Patent: March 26, 2024
    Assignee: Biora Therapeutics, Inc.
    Inventors: Jeffrey A. Shimizu, Mitchell Lawrence Jones, Mark Sasha Drlik, Iman Niknia, Nathan John Muller, Tuyen Nguyen, Christopher Loren Wahl, Edward Mudge, Nicholas Mark Salt, Nia Eleri Stevens, Stuart Robert Abercrombie, Christopher Ian Bunce, Ryan Elliott Jones, Kevin Howe, Pejman Rahimian, Nelson Quintana
  • Publication number: 20210333498
    Abstract: The present disclosure relates to a hardened fan-out assembly having an isolated chamber for protecting routed optical fibers from exposure to epoxy resin (e.g., adhesive material).
    Type: Application
    Filed: July 31, 2019
    Publication date: October 28, 2021
    Inventors: Norin P. PAUSAN, Stuart MUDGE, Darren Craig ATKINSON, Daniel Eduardo HERRERA VELAZQUEZ, Roman KAMENIK, Emmanuel Alberto ALTAMIRANO ESCOBEDO, Patrick Jacques Ann DIEPSTRATEN
  • Patent number: 10869877
    Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation.
    Type: Grant
    Filed: March 8, 2019
    Date of Patent: December 22, 2020
    Assignee: Mayne Pharma International Pty. Ltd.
    Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
  • Publication number: 20190201421
    Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation.
    Type: Application
    Filed: March 8, 2019
    Publication date: July 4, 2019
    Applicant: Mayne Pharma International Pty Ltd.
    Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
  • Patent number: 10024953
    Abstract: Various techniques are disclosed for providing a radar system. In one example, such a radar system includes a radar unit adapted to broadcast radar signals and receive return signals in response thereto. The radar unit includes a waveform generator adapted to provide pulse waveforms of different pulse widths and Frequency Modulated Continuous Wave (FMCW) waveforms, wherein the waveforms are interleaved with each other to provide a transmission sequence for the radar signals for detection of long range and short range targets, a power amplifier adapted to amplify the radar signals for broadcast, and an antenna adapted to broadcast the radar signals and receive the return signals. Other examples of radar systems and related methods are also provided.
    Type: Grant
    Filed: April 7, 2017
    Date of Patent: July 17, 2018
    Assignee: FLIR Systems, Inc.
    Inventors: Stuart Johnson, Richard Jales, Stuart Mudge, Larry Yeomans, Chris Freeman, Stewart Lawton, Steve Tostevin
  • Publication number: 20170315209
    Abstract: Various techniques are disclosed for providing a radar system. In one example, such a radar system includes a radar unit adapted to broadcast radar signals and receive return signals in response thereto. The radar unit includes a waveform generator adapted to provide pulse waveforms of different pulse widths and Frequency Modulated Continuous Wave (FMCW) waveforms, wherein the waveforms are interleaved with each other to provide a transmission sequence for the radar signals for detection of long range and short range targets, a power amplifier adapted to amplify the radar signals for broadcast, and an antenna adapted to broadcast the radar signals and receive the return signals. Other examples of radar systems and related methods are also provided.
    Type: Application
    Filed: April 7, 2017
    Publication date: November 2, 2017
    Inventors: Stuart Johnson, Richard Jales, Stuart Mudge, Larry Yeomans, Chris Freeman, Stewart Lawton, Steve Tostevin
  • Publication number: 20170182070
    Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation.
    Type: Application
    Filed: December 5, 2016
    Publication date: June 29, 2017
    Applicant: Mayne Pharma International Pty Ltd.
    Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
  • Patent number: 9618605
    Abstract: Various techniques are disclosed for providing a radar system. In one example, such a radar system includes a radar unit adapted to broadcast radar signals and receive return signals in response thereto. The radar unit includes a waveform generator adapted to provide pulse waveforms of different pulse widths and Frequency Modulated Continuous Wave (FMCW) waveforms, wherein the waveforms are interleaved with each other to provide a transmission sequence for the radar signals for detection of long range and short range targets, a power amplifier adapted to amplify the radar signals for broadcast, and an antenna adapted to broadcast the radar signals and receive the return signals. Other examples of radar systems and related methods are also provided.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: April 11, 2017
    Assignee: FLIR Systems, Inc.
    Inventors: Stuart Johnson, Richard Jales, Stuart Mudge, Larry Yeomans, Chris Freeman, Stewart Lawton, Steve Tostevin
  • Patent number: 9511031
    Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation.
    Type: Grant
    Filed: December 17, 2015
    Date of Patent: December 6, 2016
    Assignee: Mayne Pharma International Pty. Ltd.
    Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
  • Patent number: 9446057
    Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.
    Type: Grant
    Filed: November 12, 2015
    Date of Patent: September 20, 2016
    Assignee: Mayne Pharma International Pty. Ltd.
    Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
  • Publication number: 20160263129
    Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.
    Type: Application
    Filed: May 23, 2016
    Publication date: September 15, 2016
    Applicant: Mayne Pharma International Pty Ltd.
    Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
  • Publication number: 20160101052
    Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.
    Type: Application
    Filed: October 23, 2014
    Publication date: April 14, 2016
    Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
  • Publication number: 20160101060
    Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduced side effects such as nausea and irritation.
    Type: Application
    Filed: December 17, 2015
    Publication date: April 14, 2016
    Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
  • Publication number: 20160101119
    Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.
    Type: Application
    Filed: November 12, 2015
    Publication date: April 14, 2016
    Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge
  • Patent number: 9295652
    Abstract: The disclosure provides controlled release compositions comprising tetracyclines and in some embodiments, doxycycline. The controlled release doxycycline compositions of the invention exhibit a superior dissolution profile and provide reduce side effects such as nausea and irritation.
    Type: Grant
    Filed: October 23, 2014
    Date of Patent: March 29, 2016
    Assignee: Mayne Pharma International Pty. Ltd.
    Inventors: Stefan Lukas, Angelo Lepore, Stuart Mudge